Application Sponsors
ANDA 208436 | TEVA PHARMS USA | |
Marketing Status
None (Tentative Approval) | 001 |
FDA Submissions
UNKNOWN; | ORIG | 1 | TA | 2017-10-06 | STANDARD |
Submissions Property Types
CDER Filings
TEVA PHARMS USA
cder:Array
(
[0] => Array
(
[ApplNo] => 208436
[companyName] => TEVA PHARMS USA
[docInserts] => ["",""]
[products] => [{"drugName":"AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE","activeIngredients":"AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE","strength":"EQ 0.125MG BASE\/SPRAY;0.05MG\/SPRAY","dosageForm":"SPRAY, METERED;NASAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"10\/06\/2017","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2017-10-06
)
)